Mundipharma Research Becomes Latest Life Sciences Organization to Implement New User Experience Version of CSC’s FirstDoc R...
January 18 2017 - 8:00AM
Business Wire
CSC (NYSE:CSC), a global leader in next-generation IT services
and solutions, today announced that Mundipharma Research is the
latest life sciences organization working globally to go live with
CSC FirstDoc User Experience, the latest version of its market
leading RIM (regulatory information management) solution for the
life sciences industry.
CSC’s FirstDoc offering helps life sciences companies meet
increasingly rigid regulatory scrutiny and compliance procedures.
This latest User Experience version provides an enhanced
web-delivered user interface, which makes it easier for regulatory
professionals to collaborate in real-time, both inside and outside
the organization.
Jon Sanford, head of Regulatory Information Management and
Operations at Mundipharma Research said: “We are very excited about
the productivity benefits the enhanced FirstDoc User Experience can
bring in terms of improved usability and performance, as well as
providing better access to our remote users and external partners.
From day one, our users were clearly realizing these benefits and
they are providing extremely positive feedback as they are now
getting work done faster and easier than ever before.
The functionalities of this version of FirstDoc clearly
demonstrates to us that CSC’s continued investment and commitment
in the solution is delivering real innovation,” Sanford
concluded.
Jason Halpern, solution director, Global Life Sciences, at CSC
said: “We continue to innovate FirstDoc around the user experience
and regulatory process. By building a rich, flexible, and
personalized user experience on top of our industry best-in-class
rules engine, regulatory professionals globally can work more
efficiently and collaboratively.”
FirstDoc User Experience has been developed from the user’s
point of view, with flexible navigation to reduce the amount of
time required to become productive. Its browser-agnostic,
independent web interface allows the user to quickly access and
share information anywhere, using desktop, tablet or mobile
devices. Users gain a personalized experience and are able to
easily search and bookmark favorite documents, collaborate with
affiliates, create collections of documents, and share information
in real-time with business partners and regulators.
CSC and Mundipharma Research have a longstanding relationship
dating back more than 10 years. CSC has implemented regulatory
information solutions and business process services, which has
resulted in Mundipharma Research being able to:
- Maintain compliance with global
regulatory authorities;
- Enable effective planning, tracking and
reporting of regulatory applications;
- Enable quick decision making with
accurate and consistent data; and
- Create a personalized interface with
flexible navigation, to allow their employees to customize how they
view regulatory information based on their specific role and
requirements.
About CSC
CSC (NYSE: CSC) leads clients on their digital
transformation journeys. The company provides innovative
next-generation technology services and solutions that leverage
deep industry expertise, global scale, technology independence and
an extensive partner community. CSC serves leading commercial and
international public sector organizations throughout the world. CSC
is a Fortune 500 company and ranked among the best corporate
citizens. For more information, visit the company’s website
at www.csc.com.
About Mundipharma Research
Mundipharma Research comprises of two independent associated
companies, Mundipharma Research Limited in Cambridge England and
Mundipharma Research GmbH of Limburg, Germany who are wholly
dedicated to the research and development of innovative medications
in three main therapeutic areas - pain, oncology and respiratory
diseases. Mundipharma Research works on behalf of their independent
associated companies and also in collaboration with other
pharmaceutical companies to bring medications to an international
market. For more information, visit the company’s website at
www.mundipharma-rd.eu.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170118005228/en/
CSCSara Herrmann, Corporate Media Relations+1
571-255-9863sherrmann@csc.comorCSCJoanne Davis, UK Media
Relations+44 (0) 1252-536737jdavis62@csc.comorNeil DeSilva,
Investor Relations+1 703-245-9700ndesilva@csc.com
Computer Sciences (NYSE:CSC)
Historical Stock Chart
From Sep 2024 to Oct 2024
Computer Sciences (NYSE:CSC)
Historical Stock Chart
From Oct 2023 to Oct 2024